Editorial Board for section 'Cell Therapy'

Please see the section webpage for more information on this section.

Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.

Members

*
Website
Section Editor-in-Chief
Department of Medicine, The Ottawa Hospital and University of Ottawa, Ottawa, ON, Canada
Interests: hematopoietic cell transplant; allogeneic transplant; stem cell transplant; donor health; donor selection; donor registry; umbilical cord blood; cord blood banking; cord blood transplant; regenerative therapy; regenerative medicine; acute leukemia; graft versus leukemia
* Section: Cell Therapy

Website
Section Board Member
Professor and Chairman, Department of Pediatrics, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan
Interests: cell therapy; pediatric hematology; pediatric oncology; acute lymphoblastic leukemia; CAR-T cell; CAR-NK cell

Website
Section Board Member
Staff Physician, Medical Director, CAR T-Cell Program, Division of Haematology/Oncology, Blood and Marrow Transplantation/Cellular Therapy, The Hospital for Sick Children, 555 University Avenue, Toronto, ON M5G 1X8, Canada
Interests: immunotherapy; CAR T-cells; hematopoetic stem cell transplant; graft versus leukemia effect; natural killer cells

Website
Section Board Member
Princess Margaret Hospital, Toronto, ON, Canada
Interests: allogeneic BMT; GVHD; GVL; non-relapse mortality; immunotherapy; CAR; CTL

Website
Section Board Member
Professor of Pediatrics, British Columbia Children’s Hospital Research Institute, Vancouver, BC V5Z 4H4, Canada
Interests: acute lymphocytic leukemia; clinical trials; leukemia; organ transplantation; stem cells
Back to TopTop